Evidence map›Paper›PMID 35094046›Full record

SynthesisBrain : a journal of neurology2022

Establishing gene regulatory networks from Parkinson's disease risk loci.

Sophie L Farrow, William Schierding, Sreemol Gokuladhas, Evgeniia Golovina, Tayaza Fadason, Antony A Cooper, Justin M O'Sullivan

Erratum issuedOpen access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Precision medicine and music therapy for Parkinson's Disease.Clinical parkinsonism & related disorders · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis.International journal of molecular sciences · 2022
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Sophie L FarrowLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0002-6578-4219
William SchierdingLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0001-5659-2701
Sreemol GokuladhasLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0002-1685-0259
Evgeniia GolovinaLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0001-7593-5124
Tayaza FadasonLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0002-1170-7883
Antony A CooperAustralian Parkinson's Mission, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 0000-0002-6027-2353
Justin M O'SullivanLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID 0000-0003-2927-450X
University of Auckland · NZGarvan Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The latest meta-analysis of genome-wide association studies identified 90 independent variants across 78 genomic regions associated with Parkinson's disease, yet the mechanisms by which these variants influence the development of the disease remains largely elusive. To establish the functional gene regulatory networks associated with Parkinson's disease risk variants, we utilized an approach combining spatial (chromosomal conformation capture) and functional (expression quantitative trait loci) data. We identified 518 genes subject to regulation by 76 Parkinson's variants across 49 tissues, whicih encompass 36 peripheral and 13 CNS tissues. Notably, one-third of these genes were regulated via trans-acting mechanisms (distal; risk locus-gene separated by >1 Mb, or on different chromosomes). Of particular interest is the identification of a novel trans-expression quantitative trait loci-gene connection between rs10847864 and SYNJ1 in the adult brain cortex, highlighting a convergence between familial studies and Parkinson's disease genome-wide association studies loci for SYNJ1 (PARK20) for the first time. Furthermore, we identified 16 neurodevelopment-specific expression quantitative trait loci-gene regulatory connections within the foetal cortex, consistent with hypotheses suggesting a neurodevelopmental involvement in the pathogenesis of Parkinson's disease. Through utilizing Louvain clustering we extracted nine significant and highly intraconnected clusters within the entire gene regulatory network. The nine clusters are enriched for specific biological processes and pathways, some of which have not previously been associated with Parkinson's disease. Together, our results not only contribute to an overall understanding of the mechanisms and impact of specific combinations of Parkinson's disease variants, but also highlight the potential impact gene regulatory networks may have when elucidating aetiological subtypes of Parkinson's disease.

Indexed as

Genome-Wide Association StudyParkinson DiseaseAdultGene Regulatory NetworksGenetic Predisposition to DiseaseGenomicsHumansgene regulationgeneticsParkinson’s diseaseprecision medicinespatial genomics

Identifiers

PMID35094046
PMCPMC9373962
OpenAlexW4210627448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.